相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
Lanxiang Huang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Amplifying RNA Vaccine Development
Deborah H. Fuller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
How can nanotechnology help to combat COVID-19? Opportunities and urgent need
Estefania V. R. Campos et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions
Jop Vrieze
SCIENCE (2020)
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
Swati Jain et al.
VACCINES (2020)
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The Current Status of COVID-19 Vaccines
Kenneth Lundstrom
FRONTIERS IN GENOME EDITING (2020)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
The Many Pathways of RNA Degradation
Jonathan Houseley et al.
CELL (2009)